Omada Health (OMDA) furnishes Q3 2025 results press release

Omada Health, Inc. (OMDA) reported that it issued a press release announcing financial results for the three months ended September 30, 2025.

Rhea-AI Filing Summary

Omada Health, Inc. (OMDA) reported that it issued a press release announcing financial results for the three months ended September 30, 2025. The press release is furnished as Exhibit 99.1 to a Form 8-K under Item 2.02 and, as stated, is furnished and not deemed filed under Section 18 of the Exchange Act, nor incorporated by reference except as specifically referenced.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Omada Health (OMDA) disclose in this 8-K?

It announced a press release with financial results for the three months ended September 30, 2025, furnished as Exhibit 99.1.

Which 8-K item applies to Omada Health’s disclosure?

Item 2.02 — Results of Operations and Financial Condition.

Is the information considered filed or furnished?

The information, including Exhibit 99.1, is furnished and not deemed filed under Section 18 of the Exchange Act, nor incorporated by reference except as expressly set forth.

When is the report dated?

November 6, 2025.

What is Omada Health’s trading symbol and exchange?

OMDA on The Nasdaq Stock Market LLC.

Is Omada Health identified as an emerging growth company?

Yes, it is indicated as an emerging growth company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/06/2025 - 04:07 PM Learn about SEC filing dates

0001611115false00016111152025-11-062025-11-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

November 6, 2025

Date of Report (date of earliest event reported)

Omada Health, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-42679

45-2355015

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification No.)

611 Gateway Blvd, Suite 120 South San Francisco, California

94080

(Address of Principal Executive Offices)

(Zip Code)

(888) 987-8337

Registrant's telephone number, including area code

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common stock, $0.001 par value per share			OMDA			The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

o

Item 2.02    Results of Operations and Financial Condition

On November 6, 2025, Omada Health, Inc. ("Omada") issued a press release announcing its financial results for the three months ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information furnished pursuant to Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference

into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01    Financial Statements and Exhibits

(d) Exhibits.

Ex. Number			Ex. Description
99.1			Press Release
104			Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

OMADA HEALTH, INC.

Date: November 6, 2025

By:

/s/ Sean Duffy

Sean Duffy Chief Executive Officer